Autoimmune Hemolytic Anemia After mRNA COVID Vaccine

Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Zainab, Reece, Blair R. A., Moore, J. Suzanne, Means, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777324/
https://www.ncbi.nlm.nih.gov/pubmed/35045762
http://dx.doi.org/10.1177/23247096211073258
_version_ 1784637044007370752
author Fatima, Zainab
Reece, Blair R. A.
Moore, J. Suzanne
Means, Robert T.
author_facet Fatima, Zainab
Reece, Blair R. A.
Moore, J. Suzanne
Means, Robert T.
author_sort Fatima, Zainab
collection PubMed
description Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.
format Online
Article
Text
id pubmed-8777324
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87773242022-01-22 Autoimmune Hemolytic Anemia After mRNA COVID Vaccine Fatima, Zainab Reece, Blair R. A. Moore, J. Suzanne Means, Robert T. J Investig Med High Impact Case Rep Case Report Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine. SAGE Publications 2022-01-20 /pmc/articles/PMC8777324/ /pubmed/35045762 http://dx.doi.org/10.1177/23247096211073258 Text en © 2022 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Fatima, Zainab
Reece, Blair R. A.
Moore, J. Suzanne
Means, Robert T.
Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
title Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
title_full Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
title_fullStr Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
title_full_unstemmed Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
title_short Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
title_sort autoimmune hemolytic anemia after mrna covid vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777324/
https://www.ncbi.nlm.nih.gov/pubmed/35045762
http://dx.doi.org/10.1177/23247096211073258
work_keys_str_mv AT fatimazainab autoimmunehemolyticanemiaaftermrnacovidvaccine
AT reeceblairra autoimmunehemolyticanemiaaftermrnacovidvaccine
AT moorejsuzanne autoimmunehemolyticanemiaaftermrnacovidvaccine
AT meansrobertt autoimmunehemolyticanemiaaftermrnacovidvaccine

Ejemplares similares